while in the quickly evolving industry of oncology analysis, accurate and successful mutation screening is critical for developing targeted therapies. The KRAS companies System performs a pivotal part On this landscape by giving extensive methods for KRAS mutation profiling and Examination. KRAS mutations, located in around ninety five% of RAS-rele